Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia

S Engelborghs, K De Vreese, T Van de Casteele… - Neurobiology of …, 2008 - Elsevier
To establish diagnostic performance of the cerebrospinal fluid (CSF) biomarkers β-amyloid
peptide (Aβ 1–42 ), total tau-protein (T-tau) and tau phosphorylated at threonine 181 (P-tau …

A comparison of microsatellite‐based pairwise relatedness estimators

T Van de Casteele, P Galbusera… - Molecular …, 2001 - Wiley Online Library
Studies of inbreeding depression or kin selection require knowledge of relatedness between
individuals. If pedigree information is lacking, one has to rely on genotypic information to …

Reproducibility of animal research in light of biological variation

…, MJ Kas, H Schielzeth, T Van de Casteele… - Nature Reviews …, 2020 - nature.com
Context-dependent biological variation presents a unique challenge to the reproducibility of
results in experimental animal research, because organisms’ responses to experimental …

Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV‐1‐infected treatment‐naive patients in the ARTEMIS trial

…, E Lefebvre, M Opsomer, T Van de Casteele… - HIV …, 2013 - Wiley Online Library
Objective This paper presents the final analysis of once‐daily darunavir/ritonavir ( DRV /r) vs.
lopinavir/ritonavir ( LPV /r) in treatment‐naïve HIV ‐1‐infected adults. Methods ARTEMIS ( …

Contrasting relatedness patterns in bottlenose dolphins (Tursiops sp.) with different alliance strategies

…, LM Barré, T Van de Casteele… - … of the Royal …, 2003 - royalsocietypublishing.org
Male bottlenose dolphins (Tursiops sp.) in Shark Bay have one of the most complex male
societies outside humans. Two broad mating strategies have been identified in males. In the …

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients

…, K Ruxrungtham, C Workman, T Van De Casteele… - Aids, 2011 - journals.lww.com
Objective: ODIN (Once-daily Darunavir In treatment-experieNced patients) was a phase III,
48-week, open-label study comparing once-daily vs. twice-daily darunavir/ritonavir (DRV/r) in …

[HTML][HTML] Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial

…, TN Kakuda, A Brochot, T Van de Casteele… - AIDS research and …, 2014 - Springer
Background Cobicistat is an alternative pharmacoenhancer to ritonavir. In healthy
volunteers, darunavir exposure was comparable when darunavir 800 mg once daily was co-…

[HTML][HTML] Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer's disease pathology

…, C Wintmolders, K Van Kolen, T Van De Casteele… - Scientific Reports, 2017 - nature.com
Synaptic dysfunction and disconnectivity are core deficits in Alzheimer’s disease (AD),
preceding clear changes in histopathology and cognitive functioning. Here, the early and late …

Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy …

…, K Iterbeke, T Van De Casteele… - The Journal of …, 2014 - Wiley Online Library
This study compared the bioavailability of two candidate fixed‐dose combinations (FDCs:
G003 and G004) of darunavir/cobicistat 800/150 mg with that of darunavir 800 mg and ritonavir …

[HTML][HTML] The effect of Lu AG09222 on PACAP38-and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: An interventional, randomized …

…, HM Al-Khazali, T Van de Casteele… - The Journal of …, 2023 - Springer
Background Pituitary adenylate cyclase-activating polypeptide (PACAP), structurally related
to vasoactive intestinal peptide (VIP), is one of the important mediators in the pathogenesis …